STI Testing Coverage Without Cost Sharing
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-09 — Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens: cross-connection with medical-device-classification: FDA’s Class II classification of at-home non-viral STI nucleic acid tests expands the device landscape that intersects with STI testing coverage policy. (novelty: 2)
- 2026-07-23 — To require the coverage of testing for certain sexually transmitted infections without the imposition of cost sharing, and for other purposes.: HR9946 (119th Congress) introduced 2026-07-23 and referred to Energy and Commerce, Ways and Means, Veterans’ Affairs, Armed Services, and Natural Resources committees; would require group and individual health plans, Medicare, TRICARE, VA, and IHS to cover certain STI testing without cost-sharing. (novelty: 2)
Open questions
Related
Contributing findings
To require the coverage of testing for certain sexually transmitted infections without the imposition of cost sharing, and for other purposes.
23-jul-2026
novelty 2
per-area 2
introduces